Interventional Oncology Devices Market – A Global and Regional Analysis: Focus on Cancer Type, Product Type, End Users, and Country-Wise Analysis – Analysis and Forecast, 2021-2030

$5,250$8,100

The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030.

Clear

Description

Market Report Coverage – Interventional Oncology Devices Market

Market Segmentation

• Cancer Type – Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, and Other Cancers
• End User – Hospitals, Ambulatory Surgical Centers, and Others
• Product Type – Ablation Devices (Radiofrequency Ablation, Microwave Ablation, and Cryoablation), Embolization Devices (Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization (TAE)/Bland Embolization), Supporting Devices (Catheters and Guidewires), and Next-Generation Devices (Irreversible Electroporation Ablation, Percutaneous Ethanol Ablation, High Intensity Focused Ultrasound, Laser Ablation, Photothermal Ablation, and Theranostics)

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, and Rest-of-Asia-Pacific
• Rest-of-the-World – Latin America and Middle East and Africa

Market Growth Drivers

• High Prevalence and Growing Incidences of Cancer
• Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies
• Expanding Role of Interventional Oncology in the Treatment of Cancer
• Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology

Market Challenges

• Financial Burden of Product Recalls
• Lack of Clinical Evidence for Locoregional Treatments
• Dearth of Trained Interventional Oncologists

Market Opportunities

• High Growth Opportunity in the Emerging Economies
• Emergence of Local Companies in Asia-Pacific and the Middle East and Africa

Key Companies Profiled

AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, Varian Medical Systems, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of interventional oncology devices market, they will be able to do the following:

• Understand their position compared to some of the key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of interventional oncology devices and the entry barriers because of it
• Gain insights into end-user perception with respect to the adoption of interventional oncology
• Identify some of the key players in the market and understand their valuable contribution

Key Questions Answered in the Global Interventional Oncology Devices Market Report

• What are the key trends that have a strong influence on the global interventional oncology devices market? How did the COVID-19 pandemic impact the growth of the interventional oncology devices market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of interventional oncology devices look like?
• What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
• Which leading companies are dominating the global interventional oncology devices market?
• What are the regulations about the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?
• What was the market value of the leading segments and sub-segments of the global interventional oncology devices market?
• How is each segment of the global interventional oncology devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
• Which region carries the potential for the significant expansion of key companies for the interventional oncology devices market?

Global Interventional Oncology Devices Market Industry Overview

Interventional oncology procedures are suitable for those cancer patients who do not respond to chemotherapy and are not fit for surgery. Interventional oncology procedures require devices such as embolization and ablation devices, as well as an array of support devices such as catheters.

The global interventional oncology devices market is an emerging market in the medical device ecosystem. The market comprises various key medical device companies and several start-ups developing advanced solutions for cancer treatment. Furthermore, the market also has unique products in the pipeline that would further improve the technology integration in cancer treatment. The major factors that have a positive impact on the market’s growth include high prevalence and growing incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in treatment of cancer, and availability of private and government funding for grants for research in the field of interventional oncology.

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted.

The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. The market is expected to grow at a CAGR of 12.35% during the forecast period from 2021 to 2030.

Global Interventional Oncology Devices Market Drivers

The factors driving the growth of the market include the high prevalence and growing Incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in the treatment of cancer, availability of private and government funding and grants for research in the field of interventional oncology. The field of interventional oncology is constantly evolving with the introduction of novel technologies. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Thus, as the prevalence of cancer continues to increase, especially in emerged economies, technology adoption will continue to grow. This will consequently advance the growth of interventional oncology and, subsequently, the global market.

Global Interventional Oncology Devices Market Challenges

The factors restraining the growth of the global interventional oncology devices market include the financial burden of product recalls, the lack of clinical evidence for locoregional treatments, and the dearth of trained interventional oncologists. Shortage of clinical data and increasing incidences of serious side effects associated with the use of interventional oncology devices have led to numerous instances of interventional oncology device product recalls that are critically hindering the growth of the interventional oncology devices market.

Another major restraint for the global interventional oncology devices market is the shortage of skilled interventional oncology professionals in most countries who can perform interventional oncology procedures. The situation continues to worsen, as cancer is rising faster than the rate at which new interventional oncologists are entering the field.

Global Interventional Oncology Devices Market Opportunities

High growth opportunities in the emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global interventional oncology devices market growth.

There is massive scope for interventional oncology devices in developing countries. Countries such as China, India, Australia, and South Korea possess populations with high prevalence and incidence rates of cancer, which drives the adoption of interventional oncology devices for the treatment of cancer, which would surge the overall interventional oncology devices market in these emerging countries.

Impact of COVID-19 on the Global Interventional Oncology Devices Market

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.

Market Segmentation

Global Interventional Oncology Devices Market (by Cancer Type)

The global interventional oncology devices market, on the basis of cancer type, has been segmented into liver cancer, lung cancer, kidney cancer, prostate cancer, and other cancer.

The liver cancer segment accounted for the highest share of the market, which can be attributed to high consumption of alcohol, chronic viral hepatitis, liver cirrhosis, and rise in the obesity index globally. Moreover, liver cancer is less common in the U.S. than in sub-Saharan Africa and South Asian countries. Liver cancer accounts for more than 70,000 deaths each year.

Global Interventional Oncology Devices Market (by Product Type)

The global interventional oncology devices market, on the basis of product type, has been segmented into ablation devices, embolization devices, supporting devices, and next-generation devices.

Ablation is used as the first line of treatment in a few cases of hepatocellular carcinoma, and it is also considered an important option for patients who are either not eligible for surgery or have failed chemotherapy. Furthermore, advancements in interventional oncology would propel the growth of next-generation devices in the forecast period 2021-2030.

Global Interventional Oncology Devices Market (by End User)

The global interventional oncology devices market, on the basis of end users, has been segmented into three categories, namely, hospitals, ambulatory surgical centers (ASCs), and others.

Hospitals are at the forefront in terms of interventional oncology devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of interventional oncology.

The growing prominence for outpatient surgeries and rising establishments of ASCs are the leading factors promoting the market’s growth for the global interventional oncology devices. The adoption of interventional oncology devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries.

Global Interventional Oncology Devices Market (by Region)

The different regions covered under the global interventional oncology devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominates the global interventional oncology devices market due to high prevalence of cancer, growing geriatric population, and high reimbursement rates. The Asia-Pacific interventional oncology devices market is one of the lucrative markets with immense potential for expansion by key players of the global interventional oncology market. The Asia-Pacific interventional oncology devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, and Varian Medical Systems, Inc.

Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been mergers and acquisitions followed by regulatory and legal activities.

Global Microcatheters Market: Increasing prevalence of chronic diseases such as neurovascular and cardiovascular disorders is expected to augment the market at a healthy CAGR of ~4.1% during the forecast period of 2020 to 2027

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

Executive Summary 30
1 Market 39
1.1 Global Market Outlook 40
1.1.1 Product Definition 40
1.1.1.1 Embolization Devices 40
1.1.1.2 Ablation Devices 40
1.1.1.3 Supporting Devices 40
1.1.1.4 Next-Generation Devices 40
1.1.2 Inclusion and Exclusion Criteria 41
1.1.3 Key Findings 41
1.1.4 Assumptions and Limitations 42
1.1.5 Global Market Scenario 43
1.1.5.1 Realistic Growth Scenario 43
1.1.5.2 Optimistic Growth Scenario 44
1.1.5.3 Pessimistic/Conservative Growth Scenario 44
1.2 Industry Outlook 45
1.2.1 Key Trends 45
1.2.1.1 Short-Term Impact 46
1.2.1.2 Long-Term Impact 46
1.2.2 Opportunity Assessment 46
1.2.2.1 Short-Term Potential 46
1.2.2.2 Long-Term Potential 47
1.2.3 Patent Analysis 48
1.2.3.1 Awaited Technological Developments 48
1.2.3.2 Patent Publication Growth Trend 48
1.2.3.3 Patent Analysis by Country/Cluster 49
1.2.4 Product Benchmarking 50
1.2.5 Ongoing Clinical Trial Studies 51

1.3 Impact of COVID-19 on the Global Interventional Oncology Devices Market 53
1.3.1 Impact on Facilities 53
1.3.2 Impact on Device Adoption 54
1.3.3 Impact on Market Size 54
1.3.3.1 Pre-COVID-19 Phase 54
1.3.3.2 During COVID-19 Phase 54
1.3.3.3 Post-COVID-19 Phase 55
1.3.4 Market Entry Barriers and Opportunities 55
1.4 Business Dynamics 55
1.4.1 Impact Analysis 55
1.4.2 Business Drivers 56
1.4.2.1 High Prevalence and Growing Incidences of Cancer 56
1.4.2.2 Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies 59
1.4.2.3 Expanding Role of Interventional Oncology in the Treatment of Cancer 61
1.4.2.4 Availability of Private and Government Funding and Grants for Research
in the Field of Interventional Oncology 61
1.4.3 Business Restraints 62
1.4.3.1 Financial Burden of Product Recalls 62
1.4.3.2 Lack of Clinical Evidence for Locoregional Treatments 63
1.4.3.3 Dearth of Trained Interventional Oncologists 63
1.4.4 Business Opportunities 64
1.4.4.1 High Growth Opportunity in the Emerging Economies 64
1.4.4.2 Emergence of Local Companies in Asia-Pacific and the Middle East and Africa 64
2 Application 65
2.1 Global Interventional Oncology Devices Market (by Cancer Type) 66
2.1.1 Opportunity Assessment 66
2.1.2 Growth Share Matrix 67
2.1.3 Liver Cancer 68

2.1.4 Lung Cancer 69
2.1.5 Kidney Cancer 70
2.1.6 Prostate Cancer 71
2.1.7 Other Cancers 72
2.2 Global Interventional Oncology Devices Market (by End User) 73
2.2.1 Opportunity Assessment 73
2.2.2 Growth Share Matrix 74
2.2.3 Hospitals 75
2.2.4 Ambulatory Surgical Centers 76
2.2.5 Others 77
3 Products 79
3.1 Global Interventional Oncology Devices Market (by Product Type) 80
3.1.1 Opportunity Assessment 80
3.1.2 Growth Share Matrix 81
3.1.3 Ablation Devices 82
3.1.3.1 Radiofrequency Ablation 83
3.1.3.2 Microwave Ablation 84
3.1.3.3 Cryoablation 85
3.1.4 Embolization Devices 86
3.1.4.1 Transcatheter Arterial Chemoembolization (TACE) 87
3.1.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy 88
3.1.4.3 Transcatheter Arterial Embolization (TAE)/Bland Embolization 89
3.1.5 Supporting Devices 90
3.1.5.1 Catheters 91
3.1.5.2 Guidewires 92
3.1.6 Next-Generation Devices 93
3.1.6.1 Laser Ablation 93
3.1.6.2 High Intensity Focused Ultrasound (HIFU) 94
3.1.6.3 Irreversible Electroporation Ablation (IEA) 95

3.1.6.4 Photothermal Ablation 96
3.1.6.5 Percutaneous Ethanol Ablation (PEA) 97
3.1.6.6 Theranostics 98
4 Region 99
4.1 North America Interventional Oncology Devices Market 102
4.1.1 Regulatory Framework 102
4.1.2 Market 103
4.1.2.1 Key Findings and Opportunity Assessment 103
4.1.2.2 Business Drivers 104
4.1.2.3 Business Restraints 104
4.1.2.4 Impact Analysis 105
4.1.2.5 Sizing and Forecast Analysis 105
4.1.3 Application 106
4.1.3.1 North America Interventional Oncology Devices Market (by Cancer Type) 106
4.1.3.2 North America Interventional Oncology Devices Market (by End User) 106
4.1.4 Product 107
4.1.4.1 North America Interventional Oncology Devices Market (by Product Type) 107
4.1.4.1.1 North America Interventional Oncology Devices Market (by Ablation Devices) 108
4.1.4.1.2 North America Interventional Oncology Devices Market (by Embolization Devices) 108
4.1.5 North America Interventional Oncology Devices Market (by Country) 109
4.1.5.1 U.S. 109
4.1.5.1.1 Market 109
4.1.5.1.1. 4 Business Restraints 109
4.1.5.1.1. 4 Business Drivers 109
4.1.5.1.1. 4 Sizing and Forecast Analysis 110
4.1.5.1.2 Application 110
4.1.5.1.2. 4 U.S. Interventional Oncology Devices Market (by Cancer Type) 110
4.1.5.1.2. 4 U.S. Interventional Oncology Devices Market (by End User) 111

4.1.5.1.3 Product 112
4.1.5.1.3. 4 U.S. Interventional Oncology Devices Market (by Product Type) 112
4.1.5.1.3. . 4 4 U.S. Interventional Oncology Devices Market (by Ablation Devices) 112
4.1.5.1.3. . 4 4 U.S. Interventional Oncology Devices Market (by Embolization Devices) 113
4.1.5.2 Canada 113
4.1.5.2.1 Market 113
4.1.5.2.1. 4 Business Restraints 114
4.1.5.2.1. 4 Business Drivers 114
4.1.5.2.1. 4 Sizing and Forecast Analysis 115
4.1.5.2.2 Application 115
4.1.5.2.2. 4 Canada Interventional Oncology Devices Market (by Cancer Type) 115
4.1.5.2.2. 4 Canada Oncology Devices Market (by End User) 116
4.1.5.2.3 Product 117
4.1.5.2.3. 4 Canada Interventional Oncology Devices Market (by Product Type) 117
4.1.5.2.3. . 4 4 Canada Interventional Oncology Devices Market (by Ablation Devices) 117
4.1.5.2.3. . 4 4 Canada Interventional Oncology Devices Market (by Embolization Devices) 118
4.2 Europe Interventional Oncology Devices Market 120
4.2.1 Regulatory Framework 120
4.2.2 Market 120
4.2.2.1 Key Findings and Opportunity Assessment 120
4.2.2.2 Business Drivers 122
4.2.2.3 Business Restraints 122
4.2.2.4 Impact Analysis 122
4.2.2.5 Sizing and Forecast Analysis 123
4.2.3 Application 123
4.2.3.1 Europe Interventional Oncology Devices Market (by Cancer Type) 123
4.2.3.2 Europe Interventional Oncology Devices Market (by End User) 124
4.2.4 Product 125
4.2.4.1 Europe Interventional Oncology Devices Market (by Product Type) 125
4.2.4.1.1 Europe Interventional Oncology Devices Market (by Ablation Devices) 125

4.2.4.1.2 Europe Interventional Oncology Devices Market (by Embolization Devices) 126
4.2.5 Europe Interventional Oncology Devices Market (by Country) 127
4.2.5.1 Germany 127
4.2.5.1.1 Market 127
4.2.5.1.1. 4 Business Restraints 127
4.2.5.1.1. 4 Business Drivers 127
4.2.5.1.1. 4 Sizing and Forecast Analysis 127
4.2.5.1.2 Application 128
4.2.5.1.2. 4 Germany Interventional Oncology Devices Market (by Cancer Type) 128
4.2.5.1.2. 4 Germany Interventional Oncology Devices Market (by End User) 129
4.2.5.1.3 Product 129
4.2.5.1.3. 4 Germany Interventional Oncology Devices Market (by Product Type) 129
4.2.5.1.3. . 4 4 Germany Interventional Oncology Devices Market (by Ablation Devices) 130
4.2.5.1.3. . 4 4 Germany Interventional Oncology Devices Market (by Embolization Devices) 131
4.2.5.2 France 131
4.2.5.2.1 Market 131
4.2.5.2.1. 4 Business Restraints 132
4.2.5.2.1. 4 Business Drivers 132
4.2.5.2.1. 4 Sizing and Forecast Analysis 132
4.2.5.2.2 Application 133
4.2.5.2.2. 4 France Interventional Oncology Devices Market (by Cancer Type) 133
4.2.5.2.2. 4 France Interventional Oncology Devices Market (by End User) 133
4.2.5.2.3 Product 134
4.2.5.2.3. 4 France Interventional Oncology Devices Market (by Product Type) 134
4.2.5.2.3. . 4 4 France Interventional Oncology Devices Market (by Ablation Devices) 135
4.2.5.2.3. . 4 4 France Interventional Oncology Devices Market (by Embolization Devices) 135
4.2.5.3 U.K. 136
4.2.5.3.1 Market 136
4.2.5.3.1. 4 Business Restraints 136
4.2.5.3.1. 4 Business Drivers 137

4.2.5.3.1. 4 Sizing and Forecast Analysis 137
4.2.5.3.2 Application 138
4.2.5.3.2. 4 U.K. Interventional Oncology Devices Market (by Cancer Type) 138
4.2.5.3.2. 4 U.K. Interventional Oncology Devices Market (by End User) 138
4.2.5.3.3 Product 139
4.2.5.3.3. 4 U.K. Interventional Oncology Devices Market (by Product Type) 139
4.2.5.3.3. . 4 4 U.K. Interventional Oncology Devices Market (by Ablation Devices) 140
4.2.5.3.3. . 4 4 U.K. Interventional Oncology Devices Market (by Embolization Devices) 140
4.2.5.4 Italy 141
4.2.5.4.1 Market 141
4.2.5.4.1. 4 Business Restraints 141
4.2.5.4.1. 4 Business Drivers 141
4.2.5.4.1. 4 Sizing and Forecast Analysis 141
4.2.5.4.2 Application 142
4.2.5.4.2. 4 Italy Interventional Oncology Devices Market (by Cancer Type) 142
4.2.5.4.2. 4 Italy Interventional Oncology Devices Market (by End User) 143
4.2.5.4.3 Product 144
4.2.5.4.3. 4 Italy Interventional Oncology Devices Market (by Product Type) 144
4.2.5.4.3. . 4 4 Italy Interventional Oncology Devices Market (by Ablation Devices) 144
4.2.5.4.3. . 4 4 Italy Interventional Oncology Devices Market (by Embolization Devices) 145
4.2.5.5 Rest-of-Europe 146
4.2.5.5.1 Market 146
4.2.5.5.1. 4 Business Restraints 146
4.2.5.5.1. 4 Business Drivers 146
4.2.5.5.1. 4 Sizing and Forecast Analysis 146
4.2.5.5.2 Application 147
4.2.5.5.2. 4 Rest-of-Europe Interventional Oncology Devices Market (by Cancer
Type) 147
4.2.5.5.2. 4 Rest-of-Europe Interventional Oncology Devices Market (by End User) 148
4.2.5.5.3 Product 148

4.2.5.5.3. 4 Rest-of-Europe Interventional Oncology Devices Market (by Product
Type) 148
4.3 Asia-Pacific Interventional Oncology Devices Market 151
4.3.1 Regulatory Framework 151
4.3.2 Market 151
4.3.2.1 Key Findings and Opportunity Assessment 151
4.3.2.2 Business Drivers 153
4.3.2.3 Business Restraints 153
4.3.2.4 Impact Analysis 153
4.3.2.5 Sizing and Forecast Analysis 154
4.3.3 Application 154
4.3.3.1 Asia-Pacific Interventional Oncology Devices Market (by Cancer Type) 154
4.3.3.2 Asia-Pacific Interventional Oncology Devices Market (by End User) 155
4.3.4 Product 156
4.3.4.1 Asia-Pacific Interventional Oncology Devices Market (by Product Type) 156
4.3.4.1.1 Asia-Pacific Interventional Oncology Devices Market (by Ablation Devices) 157
4.3.4.1.2 Asia-Pacific Interventional Oncology Devices Market (by Embolization Devices) 157
4.3.5 Asia-Pacific Interventional Oncology Devices Market (by Country) 158
4.3.5.1 China 158
4.3.5.1.1 Market 158
4.3.5.1.1. 4 Business Restraints 158
4.3.5.1.1. 4 Business Drivers 158
4.3.5.1.1. 4 Sizing and Forecast Analysis 159
4.3.5.1.2 Application 159
4.3.5.1.2. 4 China Interventional Oncology Devices Market (by Cancer Type) 159
4.3.5.1.2. 4 China Interventional Oncology Devices Market (by End User) 160
4.3.5.1.3 Product 161
4.3.5.1.3. 4 China Interventional Oncology Devices Market (by Product Type) 161
4.3.5.1.3. . 4 4 China Interventional Oncology Devices Market (by Ablation Devices) 161
4.3.5.1.3. . 4 4 China Interventional Oncology Devices Market (by Embolization Devices) 162

4.3.5.2 Japan 162
4.3.5.2.1 Market 162
4.3.5.2.1. 4 Business Restraints 163
4.3.5.2.1. 4 Business Drivers 163
4.3.5.2.1. 4 Sizing and Forecast Analysis 163
4.3.5.2.2 Application 164
4.3.5.2.2. 4 Japan Interventional Oncology Devices Market (by Cancer Type) 164
4.3.5.2.2. 4 Japan Interventional Oncology Devices Market (by End User) 164
4.3.5.2.3 Product 165
4.3.5.2.3. 4 Japan Interventional Oncology Devices Market (by Product Type) 165
4.3.5.2.3. . 4 4 Japan Interventional Oncology Devices Market (by Ablation Devices) 166
4.3.5.2.3. . 4 4 Japan Interventional Oncology Devices Market (by Embolization Devices) 166
4.3.5.3 India 167
4.3.5.3.1 Market 167
4.3.5.3.1. 4 Business Restraints 167
4.3.5.3.1. 4 Business Drivers 168
4.3.5.3.1. 4 Sizing and Forecast Analysis 168
4.3.5.3.2 Application 169
4.3.5.3.2. 4 India Interventional Oncology Devices Market (by Cancer Type) 169
4.3.5.3.2. 4 India Interventional Oncology Devices Market (by End User) 169
4.3.5.3.3 Product 170
4.3.5.3.3. 4 India Interventional Oncology Devices Market (by Product Type) 170
4.3.5.3.3. . 4 4 India Interventional Oncology Devices Market (by Ablation Devices) 171
4.3.5.3.3. . 4 4 India Interventional Oncology Devices Market (by Embolization Devices) 171
4.3.5.4 Australia 172
4.3.5.4.1 Market 172
4.3.5.4.1. 4 Business Restraints 172
4.3.5.4.1. 4 Business Drivers 172
4.3.5.4.1. 4 Sizing and Forecast Analysis 173
4.3.5.4.2 Application 173
4.3.5.4.2. 4 Australia Interventional Oncology Devices Market (by Cancer Type) 173

4.3.5.4.2. 4 Australia Interventional Oncology Devices Market (by End User) 174
4.3.5.4.3 Product 175
4.3.5.4.3. 4 Australia Interventional Oncology Devices Market (by Product Type) 175
4.3.5.4.3. . 4 4 Australia Interventional Oncology Devices Market (by Ablation Devices) 176
4.3.5.4.3. . 4 4 Australia Interventional Oncology Devices Market (by Embolization Devices) 176
4.3.5.5 Rest-of-Asia-Pacific 177
4.3.5.5.1 Market 177
4.3.5.5.1. 4 Business Restraints 177
4.3.5.5.1. 4 Business Drivers 177
4.3.5.5.1. 4 Sizing and Forecast Analysis 177
4.3.5.5.2 Application 178
4.3.5.5.2. 4 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Cancer
Type) 178
4.3.5.5.2. 4 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by End User) 179
4.3.5.5.3 Product 180
4.3.5.5.3. 4 Rest-of-Asia-Pacific Interventional Oncology Devices Market (by Product
Type) 180
4.4 Rest-of-the-World Interventional Oncology Devices Market 181
4.4.1 Regulatory Framework 181
4.4.2 Market 181
4.4.2.1 Key Findings and Opportunity Assessment 181
4.4.2.2 Business Drivers 182
4.4.2.3 Business Restraints 182
4.4.2.4 Impact Analysis 183
4.4.2.5 Sizing and Forecast Analysis 183
4.4.3 Application 184
4.4.3.1 Rest-of-the-World Interventional Oncology Devices Market (by Cancer Type) 184
4.4.3.2 Rest-of-the-World Interventional Oncology Devices Market (by End User) 184
4.4.4 Product 185

4.4.4.1 Rest-of-the-World Interventional Oncology Devices Market (by Product Type) 185
4.4.4.1.1 Rest-of-the-World Interventional Oncology Devices Market (by Ablation Devices) 186
4.4.4.1.2 Rest-of-the-World Interventional Oncology Devices Market (by Embolization Devices) 186
4.4.5 Rest-of-the-World Interventional Oncology Devices Market (by Region) 187
4.4.5.1 Latin America 187
4.4.5.1.1 Market 187
4.4.5.1.1. 4 Business Restraints 187
4.4.5.1.1. 4 Business Drivers 187
4.4.5.1.1. 4 Sizing and Forecast Analysis 188
4.4.5.1.2 Application 188
4.4.5.1.2. 4 Latin America Interventional Oncology Devices Market (by Cancer
Type) 188
4.4.5.1.2. 4 Latin America Interventional Oncology Devices Market (by End User) 189
4.4.5.1.3 Product 190
4.4.5.1.3. 4 Latin America Interventional Oncology Devices Market (by Product
Type) 190
4.4.5.2 Middle East and Africa 190
4.4.5.2.1 Market 190
4.4.5.2.1. 4 Business Restraints 191
4.4.5.2.1. 4 Business Drivers 191
4.4.5.2.1. 4 Sizing and Forecast Analysis 191
4.4.5.2.2 Application 192
4.4.5.2.2. 4 Middle East and Africa Interventional Oncology Devices Market (by Cancer Type) 192
4.4.5.2.2. 4 Middle East and Africa Oncology Devices Market (by End User) 192
4.4.5.2.3 Product 193
4.4.5.2.3. 4 Middle East and Africa Interventional Oncology Devices Market (by Product Type) 193

5 Markets – Competitive Benchmarking & Company Profiles 194
5.1 Competitive Benchmarking and Company Profiles 195
5.1.1 Competitive Landscape 195
5.1.1.1 Key Strategies and Developments 195
5.1.1.1.1 Mergers and Acquisitions 196
5.1.1.1.2 Regulatory and Legal Activities 197
5.1.1.1.3 New Offerings 197
5.1.1.1.4 Partnerships, Alliances, and Business Expansion 198
5.1.1.1.5 Funding Activities 199
5.2 Market Share Analysis 199
5.3 Company Profiles 201
5.3.1 AngioDynamics, Inc. 201
5.3.1.1 Company Overview 201
5.3.1.2 Role of AngioDynamics, Inc. in the Global Interventional Oncology Devices Market 201
5.3.1.3 Financials 202
5.3.1.4 Recent Developments 204
5.3.1.5 SWOT Analysis 205
5.3.2 Becton, Dickinson and Company 206
5.3.2.1 Company Overview 206
5.3.2.2 Role of Becton, Dickinson, and Company in the Global Interventional Oncology Devices Market 206
5.3.2.3 Financials 207
5.3.2.4 Recent Developments 209
5.3.2.5 SWOT Analysis 209
5.3.3 Boston Scientific Corporation 211
5.3.3.1 Company Overview 211
5.3.3.2 Role of Boston Scientific Corporation in the Global Interventional Oncology Devices Market 211
5.3.3.3 Financials 212

5.3.3.4 Recent Developments 214
5.3.3.5 SWOT Analysis 215
5.3.4 Eckert & Ziegler BEBIG AG 216
5.3.4.1 Company Overview 216
5.3.4.2 Role of Eckert & Ziegler BEBIG AG in the Global Interventional Oncology Devices Market 216
5.3.4.3 Financials 217
5.3.4.4 Recent Developments 220
5.3.4.5 SWOT Analysis 220
5.3.5 HealthTronics, Inc. 221
5.3.5.1 Company Overview 221
5.3.5.2 Role of HealthTronics, Inc. in the Global Interventional Oncology Devices Market 221
5.3.5.3 SWOT Analysis 222
5.3.6 IceCure Medical Ltd 223
5.3.6.1 Company Overview 223
5.3.6.2 Role of IceCure Medical Ltd in the Global Interventional Oncology Devices Market 223
5.3.6.3 Recent Developments 224
5.3.6.4 SWOT Analysis 224
5.3.7 Johnson & Johnson 226
5.3.7.1 Company Overview 226
5.3.7.2 Role of Johnson & Johnson in the Global Interventional Oncology Devices Market 226
5.3.7.3 Financials 227
5.3.7.4 Recent Developments 229
5.3.7.5 SWOT Analysis 229
5.3.8 Medtronic plc 230
5.3.8.1 Company Overview 230
5.3.8.2 Role of Medtronic plc in the Global Interventional Oncology Devices Market
…………………………………………………………………………………………………………. 230

5.3.8.3 Financials 231
5.3.8.4 Recent Developments 233
5.3.8.5 SWOT Analysis 233
5.3.9 MedWaves, Inc. 234
5.3.9.1 Company Overview 234
5.3.9.2 Role of MedWaves, Inc. in the Global Interventional Oncology Devices Market 234
5.3.9.3 SWOT Analysis 235
5.3.10 Merit Medical Systems, Inc. 236
5.3.10.1 Company Overview 236
5.3.10.2 Role of Merit Medical Systems, Inc. in the Global Interventional Oncology Devices Market 236
5.3.10.3 Financials 237
5.3.10.4 Recent Developments 239
5.3.10.5 SWOT Analysis 239
5.3.11 Sanarus Technologies, Inc. 241
5.3.11.1 Company Overview 241
5.3.11.2 Role of Sanarus Technologies, Inc. in the Global Interventional Oncology Devices Market 241
5.3.11.3 SWOT Analysis 242
5.3.12 Sonablate Corp 243
5.3.12.1 Company Overview 243
5.3.12.2 Role of Sonablate Corp in the Global Interventional Oncology Devices Market 243
5.3.12.3 Recent Developments 244
5.3.12.4 SWOT Analysis 244
5.3.13 Terumo Corporation 245
5.3.13.1 Company Overview 245
5.3.13.2 Role of Terumo Corporation in the Global Interventional Oncology Devices Market 245
5.3.13.3 Financials 246

5.3.13.4 Recent Developments 248
5.3.13.5 SWOT Analysis 248
5.3.14 Trod Medical 250
5.3.14.1 Company Overview 250
5.3.14.2 Role of Trod Medical in the Global Interventional Oncology Devices Market 250
5.3.14.3 Recent Developments 251
5.3.14.4 SWOT Analysis 251
5.3.15 Varian Medical Systems, Inc. 252
5.3.15.1 Company Overview 252
5.3.15.2 Role of Varian Medical Systems, Inc. in the Global Interventional Oncology Devices Market 252
5.3.15.3 Financials 253
5.3.15.4 Recent Developments 255
5.3.15.5 SWOT Analysis 256
6 Research Methodology 257
6.1 Data Collection and Analysis 257
6.2 Data Sources 258
6.2.1 Primary Sources 258
6.2.2 Secondary Sources 258
6.3 Data Triangulation 260
6.4 Market Estimation 261
6.5 Assumptions and Limitation 262Attached in the mail